Skip to main content
Top
Published in: Abdominal Radiology 6/2021

Open Access 01-06-2021 | Computed Tomography | Special Section: Ovarian tumors

A radiomic nomogram based on arterial phase of CT for differential diagnosis of ovarian cancer

Authors: Yumin Hu, Qiaoyou Weng, Haihong Xia, Tao Chen, Chunli Kong, Weiyue Chen, Peipei Pang, Min Xu, Chenying Lu, Jiansong Ji

Published in: Abdominal Radiology | Issue 6/2021

Login to get access

Abstract

Purpose

To develop and validate a radiomic nomogram based on arterial phase of CT to discriminate the primary ovarian cancers (POCs) and secondary ovarian cancers (SOCs).

Methods

A total of 110 ovarian cancer patients in our hospital were reviewed from January 2010 to December 2018. Radiomic features based on the arterial phase of CT were extracted by Artificial Intelligence Kit software (A.K. software). The least absolute shrinkage and selection operation regression (LASSO) was employed to select features and construct the radiomics score (Rad-score) for further radiomics signature calculation. Multivariable logistic regression analysis was used to develop the predicting model. The predictive nomogram model was composed of rad-score and clinical data. Nomogram discrimination and calibration were evaluated.

Results

Two radiomic features were selected to build the radiomics signature. The radiomics nomogram that incorporated 2 radiomics signature and 2 clinical factors (CA125 and CEA) showed good discrimination in training cohort (AUC 0.854), yielding the sensitivity of 78.8% and specificity of 90.7%, which outperformed the prediction model based on radiomics signature or clinical data alone. A visualized differential nomogram based on the radiomic score, CEA, and CA125 level was established. The calibration curve demonstrated the clinical usefulness of the proposed nomogram.

Conclusion

The presented nomogram, which incorporated radiomic features of arterial phase of CT with clinical features, could be useful for differentiating the primary and secondary ovarian cancers.
Literature
5.
go back to reference Tanaka YO, Okada S, Satoh T, Matsumoto K, Oki A, Saida T, et al (2013) Diversity in size and signal intensity in multilocular cystic ovarian masses: new parameters for distinguishing metastatic from primary mucinous ovarian neoplasms. J Magn Reson Imaging. 38(4):794-801. https://doi.org/10.1002/jmri.24058CrossRefPubMed Tanaka YO, Okada S, Satoh T, Matsumoto K, Oki A, Saida T, et al (2013) Diversity in size and signal intensity in multilocular cystic ovarian masses: new parameters for distinguishing metastatic from primary mucinous ovarian neoplasms. J Magn Reson Imaging. 38(4):794-801. https://​doi.​org/​10.​1002/​jmri.​24058CrossRefPubMed
15.
go back to reference Lee G, Lee HY, Park H, Schiebler ML, Ejr VB, Ohno Y, et al (2016) Radiomics and its emerging role in lung cancer research, imaging biomarkers and clinical management: State of the art. European Journal of Radiology. 86:297.CrossRef Lee G, Lee HY, Park H, Schiebler ML, Ejr VB, Ohno Y, et al (2016) Radiomics and its emerging role in lung cancer research, imaging biomarkers and clinical management: State of the art. European Journal of Radiology. 86:297.CrossRef
19.
go back to reference Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, Aerts HJWL (2007) Radiomics: Extracting more information from medical images using advanced feature analysis. European Journal of Cancer. 43(4):441-46.CrossRef Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, Aerts HJWL (2007) Radiomics: Extracting more information from medical images using advanced feature analysis. European Journal of Cancer. 43(4):441-46.CrossRef
20.
go back to reference Kumar V, Gu Y, Basu S, Berglund A, Eschrich SA (2012) Radiomics: the process and the challenges. Magnetic Resonance Imaging. 30(9):1234-48.CrossRef Kumar V, Gu Y, Basu S, Berglund A, Eschrich SA (2012) Radiomics: the process and the challenges. Magnetic Resonance Imaging. 30(9):1234-48.CrossRef
24.
go back to reference Kim NH, Mi YL, Park JH, Dong IP, Jung YS (2017) Serum CEA and CA 19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia. Clinical Laboratory. 58(5):918. Kim NH, Mi YL, Park JH, Dong IP, Jung YS (2017) Serum CEA and CA 19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia. Clinical Laboratory. 58(5):918.
Metadata
Title
A radiomic nomogram based on arterial phase of CT for differential diagnosis of ovarian cancer
Authors
Yumin Hu
Qiaoyou Weng
Haihong Xia
Tao Chen
Chunli Kong
Weiyue Chen
Peipei Pang
Min Xu
Chenying Lu
Jiansong Ji
Publication date
01-06-2021
Publisher
Springer US
Published in
Abdominal Radiology / Issue 6/2021
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-021-03120-w

Other articles of this Issue 6/2021

Abdominal Radiology 6/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine